Sara Tolaney, MD, MPH

Sara Tolaney, MD, MPH, is from the Dana-Farber Cancer Institute.

Articles by Sara Tolaney, MD, MPH
HER2+ Horizons: Debates and Decisions in Metastatic Breast Cancer: Episode 1
Sara Tolaney, MD, MPHHER2 Breast Cancer | July 14, 2025
Dr. Sara Tolaney explores how DESTINY-Breast09 may reshape first-line treatment in HER2+ metastatic breast cancer.
Listen Now
Interpreting ASCENT-04 Findings With Dr. Sarah Tolaney
Sara Tolaney, MD, MPHTriple-Negative Breast Cancer | June 6, 2025
Sacituzumab + pembrolizumab improved PFS vs chemo in PD-L1+ TNBC in ASCENT-04, with no new safety signals.
View More
HER2CLIMB-02 Study Data Assesses Trastuzumab Plus Tucatinib in Patients With HER2+ Breast Cancer: How Does This Fit Into the Treatment Paradigm?
Oncology BrothersHER2 Breast Cancer | March 26, 2025
Will HER2CLIMB-02 study data impact the breast cancer landscape?
View More

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Editorial Policy

    Advertising

    Connect

    Contact Us

    eNewsletters

    Contribute

    Career Center

    Our Network

    MashupMD

    Blood Cancers Today

    Cancer Nursing Today

    GU Oncology Now

    Urban Health Today

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |